GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.52 $2.23 Monday, 22nd Apr 2024 CYCC stock ended at $1.75. This is 1.69% less than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 11.56% from a day low at $1.73 to a day high of $1.93.
90 days $1.52 $3.08
52 weeks $1.52 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Dec 02, 2020 $3.75 $4.19 $3.69 $4.12 615 811
Dec 01, 2020 $4.00 $4.00 $3.71 $3.75 108 974
Nov 30, 2020 $3.88 $3.99 $3.67 $3.92 130 944
Nov 27, 2020 $3.72 $3.98 $3.72 $3.85 97 576
Nov 25, 2020 $3.58 $3.83 $3.54 $3.73 166 037
Nov 24, 2020 $3.58 $3.61 $3.53 $3.53 20 744
Nov 23, 2020 $3.42 $3.60 $3.42 $3.51 90 740
Nov 20, 2020 $3.50 $3.50 $3.40 $3.43 84 037
Nov 19, 2020 $3.58 $3.58 $3.48 $3.52 25 238
Nov 18, 2020 $3.52 $3.59 $3.51 $3.55 29 942
Nov 17, 2020 $3.59 $3.60 $3.50 $3.50 27 665
Nov 16, 2020 $3.61 $3.61 $3.53 $3.58 56 051
Nov 13, 2020 $3.43 $3.56 $3.38 $3.54 67 527
Nov 12, 2020 $3.57 $3.62 $3.39 $3.47 45 172
Nov 11, 2020 $3.46 $3.51 $3.34 $3.51 80 939
Nov 10, 2020 $3.35 $3.45 $3.27 $3.38 56 187
Nov 09, 2020 $3.27 $3.38 $3.25 $3.33 53 980
Nov 06, 2020 $3.31 $3.31 $3.21 $3.27 27 241
Nov 05, 2020 $3.28 $3.38 $3.25 $3.28 27 960
Nov 04, 2020 $3.29 $3.39 $3.23 $3.26 24 202
Nov 03, 2020 $3.29 $3.35 $3.22 $3.28 14 266
Nov 02, 2020 $3.30 $3.30 $3.18 $3.24 56 618
Oct 30, 2020 $3.37 $3.40 $3.20 $3.26 45 986
Oct 29, 2020 $3.20 $3.42 $3.16 $3.42 91 007
Oct 28, 2020 $3.31 $3.32 $3.12 $3.21 136 530
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT